Hims & Hers Health Cash Flow from Financial Activities 2020-2025 | HIMS

Hims & Hers Health annual/quarterly cash flow from financial activities history and growth rate from 2020 to 2025. Cash flow from financial activities can be defined as the net amount of cash transactions used in funding activities
  • Hims & Hers Health cash flow from financial activities for the quarter ending March 31, 2025 was $-0.023B, a 24.05% decline year-over-year.
  • Hims & Hers Health cash flow from financial activities for the twelve months ending March 31, 2025 was $-0.280B, a 407.58% increase year-over-year.
  • Hims & Hers Health annual cash flow from financial activities for 2024 was $-0.108B, a 839.83% increase from 2023.
  • Hims & Hers Health annual cash flow from financial activities for 2023 was $-0.011B, a 65.36% decline from 2022.
  • Hims & Hers Health annual cash flow from financial activities for 2022 was $-0.033B, a 114.09% decline from 2021.
Hims & Hers Health Annual Cash Flow Financial
(Millions of US $)
2024 $-108
2023 $-11
2022 $-33
2021 $235
2020 $48
2019 $95
2018 $N/A
Sector Industry Market Cap Revenue
Medical Medical Information Systems $11.729B $1.477B
Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling medical care for numerous conditions related to mental health, sexual health, dermatology, primary care and more. Hims & Hers Health Inc., formerly known as Oaktree Acquisition Corp., is based in San Francisco.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $45.399B 58.01
Tempus AI (TEM) United States $9.423B 0.00
IRhythm Technologies (IRTC) United States $4.541B 0.00
Inspire Medical Systems (INSP) United States $4.078B 63.71
Privia Health (PRVA) United States $2.749B 187.92
Enovis (ENOV) United States $1.831B 10.21
Clover Health Investments (CLOV) United States $1.593B 0.00
Schrodinger (SDGR) United States $1.573B 0.00
Phreesia (PHR) United States $1.454B 0.00
Omnicell (OMCL) United States $1.397B 24.65
Azenta (AZTA) United States $1.251B 58.15
10x Genomics (TXG) United States $1.149B 0.00
Fulgent Genetics (FLGT) United States $0.627B 0.00
Butterfly Network (BFLY) United States $0.601B 0.00
Claritev (CTEV) United States $0.591B 0.00
Talkspace (TALK) United States $0.549B 164.00
Veradigm (MDRX) United States $0.455B 0.00
Standard BioTools (LAB) United States $0.403B 0.00
TruBridge (TBRG) United States $0.358B 793.67
Outset Medical (OM) United States $0.312B 0.00
Nyxoah SA (NYXH) Belgium $0.266B 0.00
Health Catalyst (HCAT) United States $0.260B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.191B 0.00
KORU Medical Systems (KRMD) United States $0.132B 0.00
Pulmonx (LUNG) United States $0.129B 0.00
EUDA Health Holdings (EUDA) Singapore $0.128B 0.00
American Well (AMWL) United States $0.108B 0.00
MDxHealth SA (MDXH) Belgium $0.102B 0.00
CareCloud (CCLD) United States $0.090B 3.42
111 (YI) China $0.071B 0.00
HeartBeam (BEAT) United States $0.052B 0.00
P3 Health Partners (PIII) United States $0.052B 0.00
Zepp Health (ZEPP) Netherlands $0.036B 0.00
Zhongchao (ZCMD) China $0.028B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.026B 0.00
Streamline Health Solutions (STRM) United States $0.022B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
Precipio (PRPO) United States $0.015B 0.00
MSP Recovery (MSPR) United States $0.011B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Movano (MOVE) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.003B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00